MAP1LC3A and hepatocellular carcinoma: When LC3 expression was analyzed in parallel in tumor and ANT tissues, the 3-, 5-, and 7-year cumulative incidence of HCC recurrence was found to be 13.3%, 30.9%, and 44.8%, respectively, for patients with LC3 expression in both tissues (+/+).